TY - JOUR
T1 - Blood pressure and chronic kidney disease stratified by gender and the use of antihypertensive drugs
AU - Satoh, Michihiro
AU - Hirose, Takuo
AU - Nakayama, Shingo
AU - Murakami, Takahisa
AU - Takabatake, Kyosuke
AU - Asayama, Kei
AU - Imai, Yutaka
AU - Ohkubo, Takayoshi
AU - Mori, Takefumi
AU - Metoki, Hirohito
N1 - Funding Information:
This study was supported by Grants for Scientific Research (17K15853 and 17K19930) from Ministry of Education, Culture, Sports, Science and Technology, Japan; academic contributions from Pfizer Japan Inc.; scholarship donations from Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Research Support from Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., and Bayer Yakuhin Co., Ltd.; a Health Care Science Institute Research grant; a grant from the Health Science Center; and a grant from the Foundation for Total Health Promotion.
Funding Information:
K.A., Y.I., T.O., and H.M. concurrently held the position of director of the Tohoku Institute for Management of Blood Pressure, which was supported by Omron Healthcare Co., Ltd., Division of Public Health, Hygiene, and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University received scholarship donations for education from Baxter Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. K.A. received grants Omron Healthcare Co., Ltd and personal fees from Takeda Pharmaceutical Co., Ltd. The remaining authors have no disclosures to report.
Publisher Copyright:
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2020/8/16
Y1 - 2020/8/16
N2 - BACKGROUND: The present study assessed the association between blood pressure (BP) and the risk of chronic kidney disease (CKD) according to gender and the use of antihypertensive drugs using data from a large-scale health checkup. METHODS AND RESULTS: We conducted a retrospective cohort study using the JMDC database, which contains annual health checkup data of Japanese employees and their dependents aged <75 years. We included 154 692 participants (men, 69.68%; mean age, 44.74 years) without CKD. CKD was indicated by an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or the presence of proteinuria. During the mean follow-up period of 4.78 years, new-onset CKD occurred in 14 888 participants. When the normal BP group (systolic/diastolic BP <120/<80 mm Hg) without treatment was used as a reference, the hazard ratios of the high BP (130–139/80–89 mm Hg) and grade 1 (140–159/90–99 mm Hg) and grade 2 or 3 hypertension (≥160/≥100 mm Hg) groups were 1.11 (95% CI, 1.06–1.17), 1.36 (95% CI, 1.28–1.45), and 1.76 (95% CI, 1.56–1.99) for untreated men, respectively. However, in treated men, even normal BP was associated with a 1.5-fold higher risk of CKD. The association between BP and the risk of CKD was weaker in untreated women than in untreated men. The risk of CKD in treated women with normal BP was similar to that of untreated women with normal BP. CONCLUSIONS: Gender differences were found in the association between BP and CKD risk. Kidney function in treated individuals should be followed carefully, especially in men.
AB - BACKGROUND: The present study assessed the association between blood pressure (BP) and the risk of chronic kidney disease (CKD) according to gender and the use of antihypertensive drugs using data from a large-scale health checkup. METHODS AND RESULTS: We conducted a retrospective cohort study using the JMDC database, which contains annual health checkup data of Japanese employees and their dependents aged <75 years. We included 154 692 participants (men, 69.68%; mean age, 44.74 years) without CKD. CKD was indicated by an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or the presence of proteinuria. During the mean follow-up period of 4.78 years, new-onset CKD occurred in 14 888 participants. When the normal BP group (systolic/diastolic BP <120/<80 mm Hg) without treatment was used as a reference, the hazard ratios of the high BP (130–139/80–89 mm Hg) and grade 1 (140–159/90–99 mm Hg) and grade 2 or 3 hypertension (≥160/≥100 mm Hg) groups were 1.11 (95% CI, 1.06–1.17), 1.36 (95% CI, 1.28–1.45), and 1.76 (95% CI, 1.56–1.99) for untreated men, respectively. However, in treated men, even normal BP was associated with a 1.5-fold higher risk of CKD. The association between BP and the risk of CKD was weaker in untreated women than in untreated men. The risk of CKD in treated women with normal BP was similar to that of untreated women with normal BP. CONCLUSIONS: Gender differences were found in the association between BP and CKD risk. Kidney function in treated individuals should be followed carefully, especially in men.
KW - Blood pressure
KW - Chronic kidney disease
KW - Cohort study
KW - Database
UR - http://www.scopus.com/inward/record.url?scp=85089710261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089710261&partnerID=8YFLogxK
U2 - 10.1161/JAHA.119.015592
DO - 10.1161/JAHA.119.015592
M3 - Article
C2 - 32794421
AN - SCOPUS:85089710261
SN - 2047-9980
VL - 9
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 16
M1 - e015592
ER -